CBT
SEM

CoreFirst Bank & Trust’s Select Medical SEM Stock Holding History

CoreFirst Bank & Trust’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-9,295
Closed -$111K – 411
2022
Q3 		$111K Hold
9,295
– – 0.1% 158
2022
Q2 		$118K Hold
9,295
– – 0.09% 154
2022
Q1 		$120K Hold
9,295
– – 0.08% 165
2021
Q4 		$147K Hold
9,295
– – 0.1% 154
2021
Q3 		$181K Hold
9,295
– – 0.13% 141
2021
Q2 		$212K Hold
9,295
– – 0.14% 136
2021
Q1 		$171K Hold
9,295
– – 0.12% 145
2020
Q4 		$139K Buy
+9,295
New +$121K 0.1% 146

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CoreFirst Bank & Trust's SEM Position: Q4 2022 in Review

CoreFirst Bank & Trust sold out of Select Medical (SEM) in Q4 2022, closing a stake of 9,295 shares — an estimated $111K sold.

CoreFirst Bank & Trust first reported a position in SEM in Q4 2020 and held it in 8 quarters. The position peaked at $212K in Q2 2021. 211 funds tracked by Wall St. Rank hold SEM as of Q4 2022.

  • CoreFirst Bank & Trust reported no remaining Select Medical position as of Q4 2022 after selling out during the quarter.
  • CoreFirst Bank & Trust sold 9,295 Select Medical shares in Q4 2022, an estimated $111K.
  • CoreFirst Bank & Trust first reported a position in Select Medical in Q4 2020 and held it in 8 quarters.
  • CoreFirst Bank & Trust's Select Medical position peaked at $212K in Q2 2021.
  • 211 funds tracked by Wall St. Rank held Select Medical as of Q4 2022.

Based on CoreFirst Bank & Trust's 13F filing for Q4 2022, filed 16 Feb 2023.